BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38380557)

  • 1. Factors affecting accuracy of clinical staging in resectable non-small cell lung cancer in a real-world study.
    Gwon HR; La Woo A; Yong SH; Park Y; Kim SY; Kim EY; Jung JY; Kang YA; Park MS; Park SY; Lee SH
    Thorac Cancer; 2024 Mar; 15(9):730-737. PubMed ID: 38380557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is it necessary to sample the contralateral nodal stations by EBUS-TBNA in patients with lung cancer and clinical N0 / N1 on PET-CT?
    Serra P; Centeno C; Sanz-Santos J; Torky M; Baeza S; Mendiluce L; Martínez-Barenys C; López de Castro P; Abad J; Rosell A; Andreo F
    Lung Cancer; 2020 Apr; 142():9-12. PubMed ID: 32062200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endobronchial ultrasound in real life: primary diagnosis and mediastinal staging of lung cancer in patients submitted to thoracic surgery.
    Steinhauser Motta JP; Kempa AT; Pinto Cardoso A; Paschoal ME; Raggio Luiz R; Lapa E Silva JR; Stanzel F
    BMC Pulm Med; 2016 Jul; 16(1):101. PubMed ID: 27435209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Endobronchial Ultrasound-guided Mediastinal Staging Versus Positron Emission Tomography for Comprehensive Mediastinal Staging in NSCLC Before Radical Radiotherapy of Non-small Cell Lung Cancer: A Pilot Study.
    Steinfort DP; Siva S; Leong TL; Rose M; Herath D; Antippa P; Ball DL; Irving LB
    Medicine (Baltimore); 2016 Feb; 95(8):e2488. PubMed ID: 26937894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of
    Al-Ibraheem A; Hirmas N; Fanti S; Paez D; Abuhijla F; Al-Rimawi D; Al-Rasheed U; Abdeljalil R; Hawari F; Alrabi K; Mansour A
    BMC Med Imaging; 2021 Mar; 21(1):49. PubMed ID: 33731050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excellence in non-small cell lung cancer staging by endobronchial-TBNA: Comparison with PET-CT and surgery.
    Ozturk A; Gullu YT
    Minim Invasive Ther Allied Technol; 2019 Aug; 28(4):213-219. PubMed ID: 30261784
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined endobronchial and esophageal endosonography for the diagnosis and staging of lung cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline, in cooperation with the European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS).
    Vilmann P; Clementsen PF; Colella S; Siemsen M; De Leyn P; Dumonceau JM; Herth FJ; Larghi A; Vazquez-Sequeiros E; Hassan C; Crombag L; Korevaar DA; Konge L; Annema JT
    Endoscopy; 2015 Jun; 47(6):545-59. PubMed ID: 26030890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limitations of PET/CT in the Detection of Occult N1 Metastasis in Clinical Stage I(T1-2aN0) Non-Small Cell Lung Cancer for Staging Prior to Stereotactic Body Radiotherapy.
    Akthar AS; Ferguson MK; Koshy M; Vigneswaran WT; Malik R
    Technol Cancer Res Treat; 2017 Feb; 16(1):15-21. PubMed ID: 26792491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An updated and validated PET/CT volumetric prognostic index for non-small cell lung cancer.
    Finkle JH; Penney BC; Pu Y
    Lung Cancer; 2018 Sep; 123():136-141. PubMed ID: 30089584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic Compared With Targeted Staging With Endobronchial Ultrasound in Patients With Lung Cancer.
    Sanz-Santos J; Serra P; Torky M; Andreo F; Centeno C; Mendiluce L; Martínez-Barenys C; López de Castro P; Ruiz-Manzano J
    Ann Thorac Surg; 2018 Aug; 106(2):398-403. PubMed ID: 29630875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Endosonographic Mediastinal Lymph Node Staging in Positron Emission Tomography and Computed Tomography Node-Negative Non-Small-Cell Lung Cancer in High-Risk Patients.
    Hegde P; Molina JC; Thivierge-Southidara M; Jain RV; Gowda A; Ferraro P; Liberman M
    Semin Thorac Cardiovasc Surg; 2020; 32(1):162-168. PubMed ID: 31325576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consistency and prognostic value of preoperative staging and postoperative pathological staging using
    Kajiyama A; Ito K; Watanabe H; Mizumura S; Watanabe SI; Yatabe Y; Gomi T; Kusumoto M
    Ann Nucl Med; 2022 Dec; 36(12):1059-1072. PubMed ID: 36264439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endobronchial ultrasonography for positron emission tomography and computed tomography-negative lymph node staging in non-small cell lung cancer.
    Shingyoji M; Nakajima T; Yoshino M; Yoshida Y; Ashinuma H; Itakura M; Tatsumi K; Iizasa T
    Ann Thorac Surg; 2014 Nov; 98(5):1762-7. PubMed ID: 25149044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.
    Miyasaka Y; Suzuki K; Takamochi K; Matsunaga T; Oh S
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):83-7. PubMed ID: 23233074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of preoperative [
    Lin JT; Li XM; Zhong WZ; Hou QY; Liu CL; Yu XY; Ye KY; Cheng YL; Du JY; Sun YQ; Zhang FG; Yan HH; Liao RQ; Dong S; Jiang BY; Liu SY; Wu YL; Yang XN
    Ann Nucl Med; 2024 Mar; 38(3):188-198. PubMed ID: 38145431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of maximum standardized uptake value with occult mediastinal lymph node metastases in cN0 non-small cell lung cancer.
    Lin JT; Yang XN; Zhong WZ; Liao RQ; Dong S; Nie Q; Weng SX; Fang XJ; Zheng JY; Wu YL
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):914-919. PubMed ID: 27113090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of EBUS-TBNA in the systematic evaluation of lymph node staging and resectability analysis in non-small cell lung cancer].
    Zou JY; Zhao WH; Chen JL; Du XK; Hu XW; Ye ZY
    Zhonghua Zhong Liu Za Zhi; 2019 Oct; 41(10):792-795. PubMed ID: 31648504
    [No Abstract]   [Full Text] [Related]  

  • 18. Improvement of non-small-cell lung cancer staging by means of positron emission tomography.
    Albes JM; Lietzenmayer R; Schott U; Schülen E; Wehrmann M; Ziemer G
    Thorac Cardiovasc Surg; 1999 Feb; 47(1):42-7. PubMed ID: 10218620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Diagnostic Accuracy for TNM Stage Among Whole-Body MRI and Coregistered PET/MRI Using 1.5-T and 3-T MRI Systems and Integrated PET/CT for Non-Small Cell Lung Cancer.
    Ohno Y; Takeshi Y; Takenaka D; Koyama H; Aoyagi K; Yui M
    AJR Am J Roentgenol; 2020 Nov; 215(5):1191-1198. PubMed ID: 32960670
    [No Abstract]   [Full Text] [Related]  

  • 20. EBUS-TBNA for mediastinal staging of centrally located T1N0M0 non-small cell lung cancer clinically staged with PET/CT.
    Serra Mitjà P; García-Cabo B; Garcia-Olivé I; Radua J; Rami-Porta R; Esteban L; Barreiro B; Call S; Centeno C; Andreo F; Obiols C; Ochoa JM; Martínez-Palau M; Reig N; Serra M; Sanz-Santos J
    Respirology; 2024 Feb; 29(2):158-165. PubMed ID: 37885329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.